Prescient Therapeutics Ltd has released a press release.
Executive Management Change
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Earlier from Prescient Therapeutics
- Virax Rights Offer Documentation - 25 May 2011
- VIR201 HIV Vaccine published in AIDS Journal
- Update on VIR201 HIV Vaccine Clinical Trial
- Terms Sheet - Skin Cancer
- Exclusive License with Transgene for Novel Skin Cancer Immun
Later from Prescient Therapeutics
- March 2016 Appendix 4C - Quarterly
- PTX Secures $7.0M Capital Raising
- Offer Document
- Replacement Entitlement Offer Prospectus
- Yale Joins PTXs Phase 1b/2 AML Clinical Trial
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics